Ethyl 5,7-dibromobenzofuran-2-carboxylate, 97%, 2g

N-(Amino-PEG5)-N-bis(PEG4-acid), 250mg

3-Formyl-2-methoxyphenylboronic Acid (contains varying amounts of Anhydride)5g

(S)-TERT-BUTYL 3-(BENZYLOXY)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 250mg

Colonne capillaire GC ROTI®Cap-1 MS, 12 m, 0,20 mm, 0,35 µm, 1 pièce(s)

N,0-Bis(trimethylsilyl)hydroxylamine, >95.0%(GC), 10g

D-2-Aminoadipic Acid>95.0%(GC)(T)5g

N-Benzylquinidinium Chloride [Chiral Phase-Transfer Catalyst]>98.0%(T)5g

PEG3-C4-OBn, 500mg

Lithium Trifluoro(trifluoromethyl)borate - Dimethyl Carbonate Complex>98.0%(T)1g

N-(4-Hydroxyphenethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 98%, 100mg

Pointes de pipettes Mμlti® Flex 1-200 μl, plates 0,4 mm, Boîte, Non stérile, 200 Pièces

Acide borique, min 99,8 %, pa, ACS, ISO, 500 g, emballage plastique.